Sectors
Lingyi Biotech Creates a Hopeful Future for Rare Genetic Disease Treatment
Limited options, high costs, and a lack of novel ideas have long hindered the treatment of rare genetic disorders. Existing therapies may manage symptoms for millions of patients worldwide, but often fall short regarding long-lasting changes. Lingyi Biotech is a clinical-stage biotechnology company that's taking a different approach.
Taking on Hit-or-Miss Mobile Issues with Pronto Mobile
With full mobile penetration and low churn rates in the US, there's simply no business case for the major operators to do better. Enter Pronto Mobile with a completely different approach.
Aurmor.ai Introduces New Approach in Brain Health for Youth Sports: Cumulative Neural Load Monitoring
Aurmor.ai is defining a new category in youth sports brain injury prevention and recovery. The company has pioneered the concept of Cumulative Neural Load (CNL), a framework for identifying, measuring, and mitigating the accumulation of repeated Motion-Induced Brain Stress (MiBS) during athletic activity.
Unleashing US Markets — The Big Beautiful On-Chain Software Systems for Crypto Adoption
While the promise of blockchain technology and decentralized finance is driving unprecedented innovation, the path to mass adoption is anything but straightforward. Five primary challenges are shaping the landscape for issuers, investors, and regulators alike.